These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders. Janeckova H; Kalivodova A; Najdekr L; Friedecky D; Hron K; Bruheim P; Adam T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):582-5. PubMed ID: 25482736 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Untargeted metabolomic analysis of urine samples for diagnosis of inherited metabolic disorders. Liu H; Zhu J; Li Q; Wang D; Wan K; Yuan Z; Zhang J; Zou L; He X; Miao J Funct Integr Genomics; 2021 Nov; 21(5-6):645-653. PubMed ID: 34585279 [TBL] [Abstract][Full Text] [Related]
5. A one-year pilot study comparing direct-infusion high resolution mass spectrometry based untargeted metabolomics to targeted diagnostic screening for inherited metabolic diseases. Willems AP; van der Ham M; Schiebergen-Bronkhorst BGM; van Aalderen M; de Barse MMJ; De Gruyter FE; van Hoek IN; Pras-Raves ML; de Sain-van der Velden MGM; Prinsen HCMT; Verhoeven-Duif NM; Jans JJM Front Mol Biosci; 2023; 10():1283083. PubMed ID: 38028537 [No Abstract] [Full Text] [Related]
6. Application of metabolite set enrichment analysis on untargeted metabolomics data prioritises relevant pathways and detects novel biomarkers for inherited metabolic disorders. Hoegen B; Hampstead JE; Engelke UFH; Kulkarni P; Wevers RA; Brunner HG; Coene KLM; Gilissen C J Inherit Metab Dis; 2022 Jul; 45(4):682-695. PubMed ID: 35546254 [TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS. Cerbo AD Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106 [TBL] [Abstract][Full Text] [Related]
8. -Omics biomarker identification pipeline for translational medicine. Bravo-Merodio L; Williams JA; Gkoutos GV; Acharjee A J Transl Med; 2019 May; 17(1):155. PubMed ID: 31088492 [TBL] [Abstract][Full Text] [Related]
10. Using random forest to detect multiple inherited metabolic diseases simultaneously based on GC-MS urinary metabolomics. Chen N; Wang HB; Wu BQ; Jiang JH; Yang JT; Tang LJ; He HQ; Linghu DD Talanta; 2021 Dec; 235():122720. PubMed ID: 34517588 [TBL] [Abstract][Full Text] [Related]
11. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project. Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264 [TBL] [Abstract][Full Text] [Related]
12. Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for. Eminoğlu FT; Koç Yekedüz M; Doğulu N; Öncül Ü; Köse E; Okulu E; Erdeve Ö; Atasay B; Arsan S Pediatr Int; 2022 Jan; 64(1):e14953. PubMed ID: 34390086 [TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data. Thistlethwaite LR; Li X; Burrage LC; Riehle K; Hacia JG; Braverman N; Wangler MF; Miller MJ; Elsea SH; Milosavljevic A Sci Rep; 2022 Apr; 12(1):6556. PubMed ID: 35449147 [TBL] [Abstract][Full Text] [Related]
14. Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra. Václavík J; Coene KLM; Vrobel I; Najdekr L; Friedecký D; Karlíková R; Mádrová L; Petsalo A; Engelke UFH; van Wegberg A; Kluijtmans LAJ; Adam T; Wevers RA J Inherit Metab Dis; 2018 May; 41(3):407-414. PubMed ID: 29139026 [TBL] [Abstract][Full Text] [Related]
15. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening. Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510 [TBL] [Abstract][Full Text] [Related]
16. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy. Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490 [No Abstract] [Full Text] [Related]
17. A Novel Clinico-Biochemical Score for Screening of Inherited Metabolic Diseases in Children. Ali O; Hafeez A; Ijaz A; Lodhi MA; Nawaz MA; Ahmed Z J Coll Physicians Surg Pak; 2018 Nov; 28(11):853-857. PubMed ID: 30369378 [TBL] [Abstract][Full Text] [Related]
18. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Gevi F; Zolla L; Gabriele S; Persico AM Mol Autism; 2016; 7():47. PubMed ID: 27904735 [TBL] [Abstract][Full Text] [Related]
19. Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience. Lenzini L; Carraro G; Avogaro A; Vitturi N Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883476 [TBL] [Abstract][Full Text] [Related]